2022 - Research.com Biology and Biochemistry in India Leader Award
The scientist’s investigation covers issues in Cancer research, Signal transduction, Biochemistry, Tissue transglutaminase and Cancer cell. His Cancer research research integrates issues from Cell growth, Small interfering RNA, Focal adhesion, Pathology and Metastasis. His Focal adhesion research focuses on Fibronectin and how it connects with Immunology.
His Signal transduction study combines topics from a wide range of disciplines, such as Receptor, Adenosine triphosphate and Function. The concepts of his Tissue transglutaminase study are interwoven with issues in Cell fate determination, Cellular differentiation, Cell function and Cell biology. His Cancer cell study integrates concerns from other disciplines, such as Cell, Cancer stem cell, Programmed cell death and Protein kinase A.
Kapil Mehta focuses on Cancer research, Tissue transglutaminase, Biochemistry, Immunology and Retinoic acid. His Cancer research research incorporates elements of Cancer cell, Cancer, Metastasis, Cancer stem cell and Small interfering RNA. His work in Small interfering RNA addresses subjects such as Pancreatic cancer, which are connected to disciplines such as Ectopic expression.
His Tissue transglutaminase research also works with subjects such as
His primary areas of investigation include Cancer research, Cancer, Cancer stem cell, Cancer cell and Metastasis. His study in Cancer research is interdisciplinary in nature, drawing from both Protein kinase B, Signal transduction, Small interfering RNA, Inflammation and Tissue transglutaminase. His work in Signal transduction covers topics such as Molecular biology which are related to areas like Twist transcription factor.
The various areas that Kapil Mehta examines in his Tissue transglutaminase study include Internal medicine and Pancreatic cancer. His Cancer research includes themes of Apoptosis, Disease and Chemotherapy. Kapil Mehta focuses mostly in the field of Metastasis, narrowing it down to matters related to Immunology and, in some cases, Cell and Carcinogenesis.
His primary scientific interests are in Cancer research, Cancer, Protein kinase B, Cell biology and Small interfering RNA. His research in Cancer research intersects with topics in Inflammation, Metastasis and In vivo. His studies in Metastasis integrate themes in fields like Cancer stem cell and Immunology.
His Immunology research is multidisciplinary, incorporating perspectives in Cancer cell and Cell type. His Cancer research is multidisciplinary, relying on both Integrative medicine, Pharmacology and Bioinformatics. His biological study spans a wide range of topics, including Cellular differentiation and Cell growth.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary Study
Gabriel Lopez-Berestein;Victor Fainstein;Roy Hopfer;Kapil Mehta.
The Journal of Infectious Diseases (1985)
ANTIPROLIFERATIVE EFFECT OF CURCUMIN (DIFERULOYLMETHANE) AGAINST HUMAN BREAST TUMOR CELL LINES
Kapil Mehta;Panayotis Pantazis;Theresa McQueen;Bharat B Aggarwal.
Anti-Cancer Drugs (1997)
Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance
Eswaran Devarajan;Aysegul A. Sahin;Jack S. Chen;Raghu R. Krishnamurthy.
Human CD38: a glycoprotein in search of a function
Fabio Malavasi;Ada Funaro;Stefano Roggero;Alberto Horenstein;Alberto Horenstein.
Immunology Today (1994)
Treatment and Prophylaxis of Disseminated Infection Due to Candida albicans in Mice with Liposome-Encapsulated Amphotericin B
G. Lopez-Berestein;R. Mehta;R. L. Hopfer;K. Mills.
The Journal of Infectious Diseases (1983)
Human CD38, a cell-surface protein with multiple functions.
Kapil Mehta;Umar Shahid;Fabio Malavasi.
The FASEB Journal (1996)
Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer.
Lan Li;Bilal Ahmed;Kapil Mehta;Razelle Kurzrock.
Molecular Cancer Therapeutics (2007)
Treatment of Systemic Fungal Infections With Liposomal Amphotericin B
Gabriel Lopez-Berestein;Gerald P. Bodey;Victor Fainstein;Michael Keating.
JAMA Internal Medicine (1989)
Human CD38: a (r)evolutionary story of enzymes and receptors.
Silvia Deaglio;Kapil Mehta;Fabio Malavasi.
Leukemia Research (2001)
Transglutaminase Regulation of Cell Function
Richard L. Eckert;Mari T. Kaartinen;Maria Nurminskaya;Alexey M. Belkin.
Physiological Reviews (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: